Havrdova E, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Relapsing Multiple Sclerosis in the OPERA I and OPERA II Trials. EAN 2017, PR1092.
Belangrijke stappen in onderzoek behandeling MS en alzheimer
sep 2019 | Dementie, Multipele Sclerose